MitoBloCK-10
CAS No. 394694-98-5
MitoBloCK-10( 3-fluoro-N'-[(E)-(5-nitrothiophen-2-yl)m )
Catalog No. M22749 CAS No. 394694-98-5
MitoBloCK-10 inhibits Tim44 binding to the precursor and to Hsp70.MitoBloCK-10 is the first small molecule modulator to attenuate protein-associated motor (PAM) complex activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 144 | Get Quote |
|
| 10MG | 216 | Get Quote |
|
| 25MG | 357 | Get Quote |
|
| 50MG | 529 | Get Quote |
|
| 100MG | 767 | Get Quote |
|
| 500MG | 1512 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMitoBloCK-10
-
NoteResearch use only, not for human use.
-
Brief DescriptionMitoBloCK-10 inhibits Tim44 binding to the precursor and to Hsp70.MitoBloCK-10 is the first small molecule modulator to attenuate protein-associated motor (PAM) complex activity.
-
DescriptionMitoBloCK-10 inhibits Tim44 binding to the precursor and to Hsp70.MitoBloCK-10 is the first small molecule modulator to attenuate protein-associated motor (PAM) complex activity.
-
In VitroCell Viability Assay Cell Line:A plasmid expressing Su9-Ura3-myc was integrated at the LEU2 locus in WT and tim23-2 strains.Concentration:100 μM.Incubation Time:30 min.Result:WT strain expressing Su9-Ura3 failed to grow, whereas the tim23-2 mutant expressing Su9-Ura3 grew much faster. The strains grew at a similar rate when the medium was supplemented with uracil.Cell Viability Assay Cell Line:HeLa cells.Concentration:0-100 μM.Incubation Time:24 h.Result:Inhibited HeLa cells vibility, with an IC50 of 17.2 μM.
-
In Vivo——
-
Synonyms3-fluoro-N'-[(E)-(5-nitrothiophen-2-yl)m
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number394694-98-5
-
Formula Weight293.28
-
Molecular FormulaC12H8FN3O3S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (426.23 mM)
-
SMILES[O-][N+](=O)c1ccc(\C=N\NC(=O)c2cccc(F)c2)s1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Itolizumab
Itolizumab (Anti-Human CD6 Recombinant Antibody) is a recombinant anti-CD6 monoclonal antibody that targets the extracellular SRCR distal domain 1 of CD6, thereby slowing T cell proliferation and inhibiting pro-inflammatory cytokine production.
-
Substance P (2-11)/D...
Substance P (2-11) is a substance P (SP) fragment peptide. Substance P (2-11) has contracting activities on guinea pig ileum. Substance P (2-11) inhibits the permeation of 3H SP in BBMEC monolayers.
-
(Rac)-Modipafant
(Rac)-Modipafantis an orally available and selective platelet-activating factor receptor (PAFR) antagonist that inhibits PAF-induced aggregation of washed platelets in rabbits, and can be used to study arthritis and ischemia/reperfusion (I/R) in the superior mesenteric artery (SMA) of the rat.
Cart
sales@molnova.com